sk&f 102922 has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Studies (sk&f 102922) | Trials (sk&f 102922) | Recent Studies (post-2010) (sk&f 102922) | Studies (1-methyl-3-isobutylxanthine) | Trials (1-methyl-3-isobutylxanthine) | Recent Studies (post-2010) (1-methyl-3-isobutylxanthine) |
---|---|---|---|---|---|
14 | 0 | 0 | 5,148 | 5 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cieslinksi, LB; Foley, JJ; Kopia, GA; Sarau, HM; Torphy, TJ; Valocik, RE; Wasserman, MA | 1 |
1 other study(ies) available for sk&f 102922 and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Chromones; Coronary Circulation; Dicarboxylic Acids; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Lipoxygenase Inhibitors; SRS-A; Sulfonamides; Vasoconstriction | 1987 |